Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-25

FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approves the original application for lisdexamfetamine dimesylate as a generic drug by Lannett Company, enabling generic supply with the same indications as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)